|Last Price||Today's Change||52-Week Range||Trading Volume|
|95.02||0.32 (+0.34%)||66.85 - 96.15||2.8 million (Below Avg)|
Market data as of 3:59PM 08/29/14. Quotes are delayed by at least 15 min.
Celgene Corporation to Present at Investor Conferences in September
08/21/2014 8:30 AM ET
Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate
08/19/2014 7:30 AM ET